Literature DB >> 8238243

Epstein-Barr virus in adult T-cell leukemia/lymphoma.

M Tokunaga1, S Imai, Y Uemura, T Tokudome, T Osato, E Sato.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a well-known human T-cell lymphotropic virus type-1-related disease. We studied Epstein-Barr virus (EBV) in the tumor cells of ATLL, to investigate the etiological significance of double infection with these viruses. We used polymerase chain reaction and EBV-encoded small RNA-1 in situ hybridization to investigate the presence of EBV and immunohistochemistry to detect EBV-related oncoproteins, such as EBV-determined nuclear antigen-2 and latent membrane protein. Polymerase chain reaction performed on DNA of frozen specimens from 96 cases of ATLL revealed that the tumor tissue from 21 cases contained EBV DNA. EBV-encoded small RNA-1 in situ hybridization performed on the paraffin sections of the polymerase chain reaction-positive cases indicated EBV in the nuclei of ATLL tumor cells in 16 cases, nine of which were in the pleomorphic nuclei. Latent membrane protein was also detected in the cytoplasm of ATLL tumor cells in 15 cases, and EBV nuclear antigen-2 was observed in the nuclei of ATLL tumor cells in 11 cases. We conclude that EBV was present within tumor cells in about 17% of cases with ATLL and expressed EBV oncoprotein in the tumor cells. It is hypothesized that EBV and human T-cell lymphotropic virus-1 may infect the same T cells in early life and may play a role in the oncogenesis of ATLL.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238243      PMCID: PMC1887181     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.

Authors:  K Takada; T Osato
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

3.  Virus production and surface marker expression in human lymphocytes immortalized following dual infection with human T-cell leukemia virus and Epstein-Barr virus.

Authors:  S Mochizuki; K Kawamura; K Maruyama
Journal:  Int J Cancer       Date:  1986-04-15       Impact factor: 7.396

4.  The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma.

Authors:  W A Blattner; V S Kalyanaraman; M Robert-Guroff; T A Lister; D A Galton; P S Sarin; M H Crawford; D Catovsky; M Greaves; R C Gallo
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

5.  Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues.

Authors:  K L Chang; Y Y Chen; D Shibata; L M Weiss
Journal:  Diagn Mol Pathol       Date:  1992-12

6.  Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type.

Authors:  T Suchi; K Tajima; K Nanba; H Wakasa; A Mikata; M Kikuchi; S Mori; S Watanabe; N Mohri; M Shamoto; K Harigaya; T Itagaki; M Matsuda; Y Kirino; K Takagi; S Fukunaga
Journal:  Acta Pathol Jpn       Date:  1979-09

7.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

Authors:  J F Jones; S Shurin; C Abramowsky; R R Tubbs; C G Sciotto; R Wahl; J Sands; D Gottman; B Z Katz; J Sklar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

Authors:  M Rowe; D T Rowe; C D Gregory; L S Young; P J Farrell; H Rupani; A B Rickinson
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  4 in total

1.  Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.

Authors:  Jingwu Xu; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.

Authors:  N Mori; Y Yatabe; K Oka; T Kinoshita; T Kobayashi; T Ono; J Asai
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan.

Authors:  Jun-ichi Miyagi; Takayoshi Toda; Hiroshi Uezato; Kouichi Ohshima; Tsuyoshi Miyakuni; Nobuyuki Takasu; Masato Masuda
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

4.  Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker.

Authors:  S Fujiwara; Y Ono
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.